by Damian Stanclik
31. July 2010 09:57
Alcon, Inc. a world leader in eye care, with more than 50 million implants sold since early 1990s, has announced the launch of their AcrySof IQ ReSTOR Multifocal Toric intraocular lens(IOL) outside of US during their annual general meeting in Paris. These lenses are designed to provide cataract patients that have astigmatism a surgical option that delivers quality vision at all distances with increased spectacle independence.
Alcon's president and CEO, Kevin Buehler, said "This is a significant advancement in IOL technology because it allows surgeons to offer their patients who have pre-existing astigmatism a lens that provides quality vision after cataract surgery".
Cataract surgery is the removal of the natural lens of the eye that has developed an opacification or clouding, which is reffered to as a cataract. During cataract surgery, a patient's cloudy natural lens in removed and replaced with a synthetic lens to restore the transparency and vision. Following the removal, an artificial intraocular lens is implanted. The IOLs that Alcon produces are trusted by surgeons worldwide for their ease of insertion, proven technology and consistent predictable outcomes.
Now, as these new, improved IOL's enter the European market, the chances for a full recovery after cataract surgery are even higher and perhaps no longer require the use of toric contact lenses.
Subscribe